Mansouri Safae, Naim Asmaa, Glaria Luis, Marsiglia Hugo
Radiotherapy Oncology Center Talavera, Grupo IMO, Spain E-mail :
Asian Pac J Cancer Prev. 2014;15(11):4727-32. doi: 10.7314/apjcp.2014.15.11.4727.
Breast cancers are becoming more frequently diagnosed at early stages with improved long term outcomes. Late normal tissue complications induced by radiotherapy must be avoided with new breast radiotherapy techniques being developed. The aim of the study was to compare dosimetric parameters of planning target volume (PTV) and organs at risk between conformal (CRT) and intensity-modulated radiation therapy (IMRT) after breast-conserving surgery.
A total of 20 patients with early stage left breast cancer received adjuvant radiotherapy after conservative surgery, 10 by 3D-CRT and 10 by IMRT, with a dose of 50 Gy in 25 sessions. Plans were compared according to dose-volume histogram analyses in terms of PTV homogeneity and conformity indices as well as organs at risk dose and volume parameters.
The HI and CI of PTV showed no difference between 3D-CRT and IMRT, V95 gave 9.8% coverage for 3D-CRT versus 99% for IMRT, V107 volumes were recorded 11% and 1.3%, respectively. Tangential beam IMRT increased volume of ipsilateral lung V5 average of 90%, ipsilateral V20 lung volume was 13%, 19% with IMRT and 3D-CRT respectively. Patients treated with IMRT, heart volume encompassed by 60% isodose (30 Gy) reduced by average 42% (4% versus 7% with 3D-CRT), mean heart dose by average 35% (495 cGy versus 1400 cGy with 3D-CRT). In IMRT minimal heart dose average is 356 cGy versus 90 cGy in 3D-CRT.
IMRT reduces irradiated volumes of heart and ipsilateral lung in high-dose areas but increases irradiated volumes in low-dose areas in breast cancer patients treated on the left side.
随着长期治疗效果的改善,乳腺癌在早期被诊断出的频率越来越高。随着新的乳腺放射治疗技术的发展,必须避免放疗引起的晚期正常组织并发症。本研究的目的是比较保乳手术后适形放疗(CRT)和调强放疗(IMRT)之间计划靶区(PTV)和危及器官的剂量学参数。
共有20例早期左乳腺癌患者在保守手术后接受辅助放疗,10例采用三维适形放疗(3D-CRT),10例采用调强放疗(IMRT),25次分割给予50 Gy剂量。根据剂量体积直方图分析,比较计划靶区的均匀性和适形指数以及危及器官的剂量和体积参数。
三维适形放疗(3D-CRT)和调强放疗(IMRT)的计划靶区高剂量区(HI)和适形指数(CI)无差异,三维适形放疗(3D-CRT)的V95覆盖率为9.8%,调强放疗(IMRT)为99%,V107体积分别记录为11%和1.3%。切线野调强放疗(IMRT)使同侧肺V5平均体积增加90%,同侧肺V20体积分别为13%(调强放疗)和19%(三维适形放疗)。调强放疗(IMRT)治疗的患者,60%等剂量线(≥30 Gy)所包含的心脏体积平均减少42%(4%对比三维适形放疗的7%),平均心脏剂量平均减少35%(495 cGy对比三维适形放疗的1400 cGy)。调强放疗(IMRT)的最小心脏剂量平均为356 cGy,三维适形放疗(3D-CRT)为90 cGy。
调强放疗(IMRT)可减少左侧乳腺癌患者高剂量区域中心脏和同侧肺的受照体积,但增加了低剂量区域的受照体积。